跳至主要内容
临床试验/EUCTR2021-002363-22-NL
EUCTR2021-002363-22-NL进行中(未招募)1 期

Vaccination of older persons against Sars-Cov-2 and cellular immunogenicity for long term protection(participating in the Doetinchem Cohort Study) - VOCAA

ational Institute for Public Health and the Environment0 个研究点目标入组 150 人开始时间: 2021年5月27日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Having participated the ISA study (part of the DCS).
  • Willing to receive the SARS-CoV-2 vaccine.
  • Willing to give the Informed Consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 140

排除标准

  • A potential subject will be excluded from participation in this study when a person already received the second primary SARS-CoV-2 vaccination more than a month earlier and has not signed the ICF at T0, T1 or T2 .

研究者

发起方
ational Institute for Public Health and the Environment

相似试验

招募中
4 期
Vaccination of older persons against Sars-Cov-2 and cellular immunogenicity for long term protection (participating in the Doetinchem Cohort Study)Immuunsysteemcoronaprevention10047438
NL-OMON54152RIVM160
招募中
不适用
Improving vaccination uptake among older adults (= 60 years)Vaccination uptake of influenza vaccination in population aged 60 and olderVaccination uptake of further recommended vaccinations for people aged 60 and older: pneumococci, herpes zoster, revaccinations (tetanus, diphtheria and pertussis), COVID-19Vaccine literacyVaccination behaviour and intention Knowledge about influenza and pneumococci
DRKS00027252Verband der Ersatzkassen e. V. (vdek), Abteilung Ambulante Versorgung,2,114
进行中(未招募)
不适用
Primary and booster vaccination in old age: Hepatitis A and Hepatitis BThis study will analyze cellular and humoral immune reponses after primary or booster vaccination against HAV and HBV. Healthy adults will be vaccinated with a combination vaccine, which is licensed for all age groups studied in this studyMedDRA version: 16.1Level: LLTClassification code 10054181Term: Hepatitis B immunizationSystem Organ Class: 100000004865MedDRA version: 16.1Level: LLTClassification code 10063436Term: Hepatitis A immunizationSystem Organ Class: 100000004865MedDRA version: 16.1Level: LLTClassification code 10068384Term: Hepatitis immunizationSystem Organ Class: 100000004865
EUCTR2013-002589-38-ATniversität Innsbruck, Institut für Biomedizinische Alternsforschung
已完成
不适用
Pneumococcal vaccination in elderly care facilities in Japan: A Cross-sectional web-based surveyPneumococcal disease
JPRN-UMIN000048747MSD K.K.450
进行中(未招募)
不适用
Pneumococcal conjugate vaccines in the elderly: The role of carrier-specific T cells
EUCTR2014-000260-17-ATniversität Innsbruck, Institut für Biomedizinische Alternsforschung